ROCKWELL MEDICAL, INC. Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
ROCKWELL MEDICAL, INC. (RMTI) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of $1.21 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2019-03-18
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2017 was $1.21M.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2016 was -$20.00K, a 102.12% decline from fiscal 2015.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2015 was $943.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month as first filed |
|---|---|---|
| 2017-12-31 | $1.21M 10-K · filed 2019-03-18 | -$1.21M 10-K · filed 2018-03-15 |
| 2016-12-31 | -$20.00K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $943.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |